Ampure Pharmaceutical Llp - Company Profile

It is a pharma limited liability partnership based in Haridwar, Uttarakhand, India, established in 2020.
2020 Haridwar, Uttarakhand, India Active
Last Updated:
Access Report
About Ampure Pharmaceutical Llp

Ampure Pharmaceutical Llp, a active limited liability partnership, was established on 16 September 2020 in Haridwar, Uttarakhand, India. Engaging in drug formulation & development within the pharma sector, it holds LLPIN: AAT-8536. Registered under ROC Roc Uttarakhand. It has total obligation of contribution of ₹5.00 M.

Its leadership includes Mithlesh Chauhan (Designated Partner), Arjun Singh Chauhan (Designated Partner). Past directors included Vishal Kumar, Pankaj Kumar. Its latest date of accounts and solvency statement 31 March 2025. It is based at Kh No. 90, Plot No. 48, First Floor, R K Puram Colony, Jamalpur Khurd,Jwalapu, R, Haridwar, Uttarakhand, 249407.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAT-8536

  • Incorporation Date

    16 September 2020

  • Total Obligation of Contribution

    ₹5.00 M

  • ROC Code

    Roc Uttarakhand

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 5.00 M
  • Company Age 5 Year, 5 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Ampure Pharmaceutical Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ampure Pharmaceutical Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Ampure Pharmaceutical Llp?
Current Designated Partners
Name Designation Appointment Date Status
Mithlesh Chauhan Designated Partner 21 Jul 2021 Current
Arjun Singh Chauhan Designated Partner 05 Dec 2025 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Designated Partner 05 Dec 2025 Past
Pramod Abcsdd Designated Partner 02 Sep 2025 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ampure Pharmaceutical Llp.

Ampure Pharmaceutical Llp, for the financial year ended 2021, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Ampure Pharmaceutical Llp revenue growth over time
Ampure Pharmaceutical Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ampure Pharmaceutical Llp?

Unlock access to Ampure Pharmaceutical Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Ampure Pharmaceutical Llp?

Unlock and access historical data on people associated with Ampure Pharmaceutical Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ampure Pharmaceutical Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ampure Pharmaceutical Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ampure Pharmaceutical Llp
Recent Activity within the Organization
  • Director Appointment

    The activity Arjun Singh Chauhan was appointed as a Designated Partner was appointed as a Designated Partner on 05 Dec 2025 & has been associated with this company since 2 months 30 days . was completed.

  • Annual General Meeting

    The activity Ampure Pharmaceutical Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    Ampure Pharmaceutical Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Uttarakhand. was recorded as a recent event.

  • Director Appointment

    Mithlesh Chauhan was appointed as a Designated Partner was appointed as a Designated Partner on 21 Jul 2021 & has been associated with this company since 4 years 7 months . was recorded as a recent event.

  • LLP Incorporation

    Progress on Ampure Pharmaceutical Llp was registered on 16 Sep 2020 with Roc Uttarakhand & aged 5 years 5 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Ampure Pharmaceutical Llp?

The LLPIN of Ampure Pharmaceutical Llp is AAT-8536.

Where is Ampure Pharmaceutical Llp headquartered?

Ampure Pharmaceutical Llp is headquartered at Kh No. 90, Plot No. 48, First Floor, R K Puram Colony, Jamalpur Khurd,Jwalapu, R, Haridwar, Uttarakhand, 249407.

When was Ampure Pharmaceutical Llp incorporated?

Ampure Pharmaceutical Llp was incorporated on 16 September 2020.

Who are the current directors of Ampure Pharmaceutical Llp?

The current directors of Ampure Pharmaceutical Llp are

What is the primary industry of Ampure Pharmaceutical Llp?

The primary industry of Ampure Pharmaceutical Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available